Valeant Pharmaceuticals’ De-Globalisation Strategy Sees the Sale of European Operations
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 99 (Table of Contents)
Published: 4 Aug-2008
DOI: 10.3833/pdr.v2008.i99.149 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Valeant Pharmaceuticals sold its Western and Eastern European pharmaceutical business to Meda, giving Meda an opportunity to enter the Russian market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018